MRK

Merck & Company, Inc.

Halal Rating :
Comfortable
Last Price $97.95 Last updated:
Market Cap $247.7b
7D Change -3.0%
1 Year Change -17.99%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NYSE
Next Earnings Date Oct. 31, 2024

Merck & Co., Inc. is a global pharmaceutical company that develops and produces medicines, vaccines, and animal health products. The company focuses on several therapeutic areas including oncology, infectious diseases, cardiovascular health, and animal health. Their key products include cancer immunotherapy Keytruda, HPV vaccine Gardasil, and diabetes medication Januvia.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $16.66b $12.73b - - 0.00% 0.00%
June 30, 2024 $16.11b $10.06b - - 0.00% 0.00%
March 31, 2024 $15.78b $10.14b - - 0.00% 0.00%

Company Impact

Help us evaluate Merck & Company, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates